Keywords: alpharma, change, kadian, labeling, usa-based, says, approval

Alpharma to change Kadian labeling

Article | 01 August 2005

Print This

USA-based Alpharma says that approval of its painkiller Kadian (morphine sulfate) 200mg extended-release capsules may be delayed as a result ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in